Lv31
308 积分 2022-11-29 加入
Preclinical application of a CD155 targeting chimeric antigen receptor T cell therapy for digestive system cancers
3小时前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
3个月前
已完结
CD155 and its receptors in cancer immune escape and immunotherapy
5个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
6个月前
已完结
Antigen experience history directs distinct functional states of CD8+ CAR T cells during the antileukemia response
6个月前
已完结
Bispecific killer cell engager-secreting CAR-T cells redirect natural killer specificity to enhance antitumour responses
6个月前
已完结
Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial
6个月前
已完结
Preclinical efficacy and pharmacokinetics of an RNA-encoded T cell–engaging bispecific antibody targeting human claudin 6
6个月前
已完结
New immune cell engagers for cancer immunotherapy
6个月前
已完结
T cell-engaging therapies — BiTEs and beyond
6个月前
已完结
皖公网安备34019202002308
